These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

614 related items for PubMed ID: 33229509

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond.
    Karin N.
    Front Immunol; 2020; 11():976. PubMed ID: 32547545
    [Abstract] [Full Text] [Related]

  • 3. Bu-Shen-Fang-Chuan formula attenuates T-lymphocytes recruitment in the lung of rats with COPD through suppressing CXCL9/CXCL10/CXCL11-CXCR3 axis.
    Li Q, Sun J, Cao Y, Liu B, Li L, Mohammadtursun N, Zhang H, Dong J, Wu J.
    Biomed Pharmacother; 2020 Mar; 123():109735. PubMed ID: 31864210
    [Abstract] [Full Text] [Related]

  • 4. CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy.
    Tokunaga R, Zhang W, Naseem M, Puccini A, Berger MD, Soni S, McSkane M, Baba H, Lenz HJ.
    Cancer Treat Rev; 2018 Feb; 63():40-47. PubMed ID: 29207310
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis.
    Hensbergen PJ, Wijnands PG, Schreurs MW, Scheper RJ, Willemze R, Tensen CP.
    J Immunother; 2005 Feb; 28(4):343-51. PubMed ID: 16000952
    [Abstract] [Full Text] [Related]

  • 7. Icaritin inhibited cigarette smoke extract-induced CD8+ T cell chemotaxis enhancement by targeting the CXCL10/CXCR3 axis and TGF-β/Smad2 signaling.
    Li Q, Sun J, Cao Y, Liu B, Zhao Z, Hu L, Zhang H, Kong Q, Wu J, Dong J.
    Phytomedicine; 2022 Feb; 96():153907. PubMed ID: 35026517
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Common variants of chemokine receptor gene CXCR3 and its ligands CXCL10 and CXCL11 associated with vascular permeability of dengue infection in peninsular Malaysia.
    Hoh BP, Umi-Shakina H, Zuraihan Z, Zaiharina MZ, Rafidah-Hanim S, Mahiran M, Khairudin NY, Benedict LH, Masliza Z, Christopher KC, Sazaly AB.
    Hum Immunol; 2015 Jun; 76(6):421-6. PubMed ID: 25858769
    [Abstract] [Full Text] [Related]

  • 11. Upregulation of angiostatic chemokines IP-10/CXCL10 and I-TAC/CXCL11 in human obesity and their implication for adipose tissue angiogenesis.
    Hueso L, Ortega R, Selles F, Wu-Xiong NY, Ortega J, Civera M, Ascaso JF, Sanz MJ, Real JT, Piqueras L.
    Int J Obes (Lond); 2018 Aug; 42(8):1406-1417. PubMed ID: 29795466
    [Abstract] [Full Text] [Related]

  • 12. Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity--a tale of conflict and conundrum.
    Müller M, Carter S, Hofer MJ, Campbell IL.
    Neuropathol Appl Neurobiol; 2010 Aug; 36(5):368-87. PubMed ID: 20487305
    [Abstract] [Full Text] [Related]

  • 13. Interferon-γ amplifies airway smooth muscle-mediated CD4+ T cell recruitment by promoting the secretion of C-X-C-motif chemokine receptor 3 ligands.
    Sun R, Jang JH, Lauzon AM, Martin JG.
    FASEB J; 2021 Jan; 35(1):e21228. PubMed ID: 33337555
    [Abstract] [Full Text] [Related]

  • 14. CXCR3 axis in patients with primary biliary cirrhosis: a possible novel mechanism of the effect of ursodeoxycholic acid.
    Manousou P, Kolios G, Drygiannakis I, Koulentaki M, Pyrovolaki K, Voumvouraki A, Notas G, Bourikas L, Papadaki HA, Kouroumalis E.
    Clin Exp Immunol; 2013 Apr; 172(1):9-15. PubMed ID: 23480180
    [Abstract] [Full Text] [Related]

  • 15. Expression and regulation of the CXCL9-11 chemokines and CXCR3 receptor in Atlantic salmon (Salmo salar).
    Valdés N, Espinoza D, Pareja-Barrueto C, Olate N, Barraza-Rojas F, Benavides-Larenas A, Cortés M, Imarai M.
    Front Immunol; 2024 Apr; 15():1455457. PubMed ID: 39301034
    [Abstract] [Full Text] [Related]

  • 16. Enhancement of antigen-specific CD8 T cell responses by co-delivery of Fc-fused CXCL11.
    Namkoong H, Song MY, Seo YB, Choi DH, Kim SW, Im SJ, Sung YC, Park Y.
    Vaccine; 2014 Feb 26; 32(10):1205-12. PubMed ID: 23928465
    [Abstract] [Full Text] [Related]

  • 17. The CXC Chemokine Receptor 3 Inhibits Autoimmune Cholangitis via CD8+ T Cells but Promotes Colitis via CD4+ T Cells.
    Liu QZ, Ma WT, Yang JB, Zhao ZB, Yan K, Yao Y, Li L, Miao Q, Gershwin ME, Lian ZX.
    Front Immunol; 2018 Feb 26; 9():1090. PubMed ID: 29868034
    [Abstract] [Full Text] [Related]

  • 18. NOD2 regulates CXCR3-dependent CD8+ T cell accumulation in intestinal tissues with acute injury.
    Wu X, Lahiri A, Haines GK, Flavell RA, Abraham C.
    J Immunol; 2014 Apr 01; 192(7):3409-18. PubMed ID: 24591373
    [Abstract] [Full Text] [Related]

  • 19. Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation.
    Loos T, Mortier A, Gouwy M, Ronsse I, Put W, Lenaerts JP, Van Damme J, Proost P.
    Blood; 2008 Oct 01; 112(7):2648-56. PubMed ID: 18645041
    [Abstract] [Full Text] [Related]

  • 20. Interferons induce CXCR3-cognate chemokine production by human metastatic melanoma.
    Dengel LT, Norrod AG, Gregory BL, Clancy-Thompson E, Burdick MD, Strieter RM, Slingluff CL, Mullins DW.
    J Immunother; 2010 Oct 01; 33(9):965-74. PubMed ID: 20948440
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.